On April 6, 2017, United States Rep. Matt Gaetz, R-Fla., announced the introduction of a bill to reschedule cannabis from Schedule I to Schedule III, shifting it from a class of drugs categorized as having no medical benefit to a class of drugs categorized as having known medical benefits paired with low rates of abuse and dependence.
U.S. Rep. Darren Soto, D-Fla., is cosponsoring the legislation, which aims to make it easier for patients, scientists and medical researchers to access medical cannabis.
“This drug should not be in the same category as heroin and LSD, and we do not need to continue with a policy that turns thousands of young people into felons every year. Nor do we need to punish the millions of people who are sick and seeking medical help – from pain, from muscle wasting, from chemotherapy-induced nausea,” Gaetz said.
“Floridians have spoken and Medical Marijuana is the law of the land. It’s now time for the federal government to recognize this emerging law and the well-known medical benefits of marijuana,” Soto added.
Gaetz took to the House floor on the morning of April 6 to introduce his proposed legislation, which you can watch below.
The U.S. Drug Enforcement Agency previously denied a petition to reschedule cannabis on Aug. 11, 2016, citing insufficient evidence from FDA-approved studies.